Evolution of the management approach for pulmonary atresia with intact ventricular septum

Y P Mi1, A K T Chau, C S W Chiu

  • 1Division of Paediatric Cardiology, Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Grantham Hospital, 125, Wong Chuk Hang Road, Aberdeen, Hong Kong, People's Republic of China.

Insights

Management of pulmonary atresia with intact ventricular septum (PAIVS) has evolved, with a shift towards transcatheter interventions reducing low cardiac output syndrome. Survival rates remain similar across different procedures for PAIVS patients.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Cardiac Surgery

Background:

  • Pulmonary atresia with intact ventricular septum (PAIVS) presents complex management challenges.
  • Historically, surgical interventions have been the mainstay for PAIVS treatment.
  • Evolving therapeutic strategies aim to improve outcomes in PAIVS patients.

Purpose of the Study:

  • To analyze the changes in PAIVS management over two decades.
  • To evaluate the impact of evolving treatment approaches on patient outcomes.
  • To compare the effectiveness of different interventions for PAIVS.

Main Methods:

  • Retrospective analysis of 94 PAIVS patients diagnosed between 1980 and 2003.
  • Review of management strategies including surgical and catheter-based interventions.
  • Assessment of patient outcomes, including reintervention rates, complications, and survival.

Main Results:

  • Transcatheter interventions, particularly laser-assisted valvotomy, showed reduced rates of low cardiac output syndrome compared to surgical RVOT reconstruction or closed pulmonary valvotomy.
  • Freedom from reintervention varied significantly between procedures, with RVOT reconstruction showing better short-term results.
  • Overall survival at one and five years was 77% and 70%, respectively, with no significant difference between intervention groups.

Conclusions:

  • The management of PAIVS often necessitates multiple interventions.
  • Increased utilization of transcatheter approaches has led to a decrease in postprocedural low cardiac output syndrome.
  • While survival rates are comparable, the choice of intervention impacts reintervention rates and acute complications.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...